REFERENCE
FDA.Information for Healthcare Professionals: micro-bubble contrast agents (marketed as Definity (perflutren lipid microsphere) injectable suspension and Optison (perflutren protein-type A microspheres for injection). Internet Document: [4 pages], 17 Jul 2008. Available from: URL: http://www.fda.gov
Rights and permissions
About this article
Cite this article
Revised labelling for micro-bubble contrast agents. React. Wkly. 1212, 2 (2008). https://doi.org/10.2165/00128415-200812120-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200812120-00002